Animal Welfare

I am sure many of your readers join me in disagreeing with the accusations made by Marjorie Anchel in her Sept. 20, 1993, letter to The Scientist [page 12]. To say that "laboratories are exempt from the anti-cruelty laws" is to ignore the fact that the biomedical research industry is one of the most highly regulated industries in the United States. The Animal Welfare Act (AWA) sets standards for the humane treatment of laboratory animals. This act has specific requirements for housing, feed

Written bySusan Paris
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

To say that "laboratories are exempt from the anti-cruelty laws" is to ignore the fact that the biomedical research industry is one of the most highly regulated industries in the United States.

The Animal Welfare Act (AWA) sets standards for the humane treatment of laboratory animals. This act has specific requirements for housing, feeding, sanitation, and ventilation. Many amendments were added to this 1966 bill that also govern the amount of living space, proper exercise, and psychological well-being of the animal. In fact, with all these regulations, some animal research laboratories cost more to build than hospitals.

Additionally, many institutions voluntarily adhere to even stricter laboratory guidelines, such as those of the American Association for Accreditation of Laboratory Animal Care (AAALAC).

Medical scientists strive to avoid excessive regulation, which does nothing for animal welfare but costs researchers time and money. These costs translate into paying more for health care and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies